FDA Panel Gives Thumbs Up to Anemia Pill for CKD Patients on Dialysis

(MedPage Today) -- A group of FDA advisors recommended approval of daprodustat for treating chronic kidney disease (CKD)-related anemia, but only for the subset of patients on dialysis, determining that the same risk-benefit profile did not exist...
Source: MedPage Today Public Health - Category: American Health Source Type: news